Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep;22(9):1241-1249.
doi: 10.1038/mp.2017.40. Epub 2017 Mar 21.

Pluripotent stem cells in neuropsychiatric disorders

Affiliations
Review

Pluripotent stem cells in neuropsychiatric disorders

M A Soliman et al. Mol Psychiatry. 2017 Sep.

Abstract

Neuropsychiatric disorders place an enormous medical burden on patients across all social and economic ranks. The current understanding of the molecular and cellular causes of neuropsychiatric disease remains limited, which leads to a lack of targeted therapies. Human-induced pluripotent stem cell (iPSC) technology offers a novel platform for modeling the genetic contribution to mental disorders and yields access to patient-specific cells for drug discovery and personalized medicine. Here, we review recent progress in using iPSC technology to model and potentially treat neuropsychiatric disorders by focusing on the most prevalent conditions in psychiatry, including depression, anxiety disorders, bipolar disorder and schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Graphic representation of disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs). (b) Graph representing the DALY burden of leading neuropsychiatric disorders, as well as comparable non-neuropsychiatric diseases.
Figure 2
Figure 2
Schematic representation of induced pluripotent stem cell generation and application. A biopsy is taken from a patient (skin, blood or other tissues). Patient cells are reprogrammed into pluripotent stem cells and differentiated into the neuronal cell types of interest. Patient-derived neurons could be used for elucidating disease mechanism, high-throughput drug screening, drug testing and toxicity studies, biomarker identification and patient stratification. iPSC, human-induced pluripotent stem cell.
Figure 3
Figure 3
Timeline of iPSC technology development. Developments of neuropsychiatric disease models are represented on the lower side of the timeline panel, whereas developments in generating specific neuronal cell populations are represented in the upper part of the panel. BPD, bipolar disorder; iPSC, human-induced pluripotent stem cell; SCZ, schizophrenia.

References

    1. Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A et al, GBD 2013 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 2015; 386: 2145–2191. - PMC - PubMed
    1. Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310: 591–608. - PMC - PubMed
    1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1575–1586. - PubMed
    1. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry 2016; 3: 171–178. - PubMed
    1. Soni A. The Five Most Costly Conditions, 1996 and 2006: Estimates for the US Civilian Noninstitutionalized Population. Statistical Brief# 248. Agency for Healthcare Research and Quality: Rockville, MD, USA, 2009.

Publication types

MeSH terms